NARSAD
Welcome, guest
[login or register]
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Diego Restrepo, Ph.D. (Distinguished Investigator 2005) of University of Colorado Health Sciences Center, notes that modern human genetics, molecular biology and functional imaging have allowed unprecedented advances in our understanding of the neural basis of schizophrenia. Thus, it is clear that this disease has both genetic and environmental causes, and mutations in several genes including the alpha 7 acetylcholine receptor gene (CHRNA7) have been implicated in schizophrenia. Although the identification of these mutations as potential factors contributing to schizophrenia is exciting, and could lead to development of new therapies, a major obstacle is the inability to determine the nature of functional changes of human neurons in schizophrenics compared to controls. Along with two other groups, Dr. Restrepo can culture human olfactory bulb neurons from cadavers from genotyped schizophrenics and controls allowing him, for the first time, to study function in neurons from schizophrenics. Building on his success culturing olfactory receptor neurons in the past, Dr. Restrepo now proposes cultures of olfactory bulb from adult rodents and humans, as model systems for the study of alterations in cellular physiology associated with genetically determined changes in a7 nicotinic receptor expression. He has targeted the study of the functional consequences of this mutation because his collaborators have identified CHRNA7 as one of the loci for mutations contributing to schizophrenia, and because these investigators have agreed to collaborate with him and provide genotyped cadaver samples of human olfactory bulb. Interestingly, although first attracted to this line of research because of the alpha7 work, he notes that dysbindin and neuregulin, two of the other genes that appear to be involved in schizophrenia are also involved in synapse formation and specifically in the formation of nicotinic synapses. Thus, his work could be extended to understand the functional role of these two other genes in neuronal dysfunction in schizophrenia.

Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Independent Investigator application deadline: March 5, 2008

2008 Young Investigator, 2008 Distinguished Investigator and 2008 Staglin Grantees Announced: March, 2008

2008 Distinguished Investigator Earliest Start Date: May 1, 2008

2009 Distinguished Investigator Award application deadline: May 15, 2008

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award application deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Award Earliest Start Date: September 15, 2008

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009





NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us